MedPath

CHUNGBUK NATIONAL UNIVERSITY HOSPITAL

🇰🇷South Korea
Ownership
-
Established
1988-01-01
Employees
-
Market Cap
-
Website
https://www.cbnuh.or.kr/

Korean Hospitals Secure Approval for SK Biopharmaceuticals' Cenobamate for Epilepsy Treatment

Two major Korean university hospitals have received therapeutic use approval for cenobamate in epilepsy treatment, marking the first medical team applications for this indication since SK Biopharmaceuticals' 2022 approval.

© Copyright 2025. All Rights Reserved by MedPath